Mark Pemberton

Mark Pemberton is an experienced professional in the pharmaceutical industry, currently serving as the Franchise Lead Neurology at Alexion Pharmaceuticals, Inc. since June 2023. Prior roles include National Sales Manager - Neuroscience at AbbVie, Commercial Director at Akcea Therapeutics, and Business Unit Director for Neuroscience at Ipsen Biopharmaceuticals Canada. Mark also held the position of Vice President for Lilly Diabetes Canada at Eli Lilly and Company from 2006 to 2016, where Mark was part of senior leadership teams and alliances. Mark's career showcases a progressive trajectory with increasing responsibilities in commercial leadership. Mark holds a Bachelor’s Degree in Commerce from McMaster University.